What is the total value of India's pharmaceutical export to Italy?

India exported pharmaceuticals worth $471.9M to Italy across 1,710 verified shipments.

Which companies in Italy import pharmaceuticals from India?

1. PFIZER PRODUCTS INDIA PRIVATE LIMITED — $97.0M. 2. SANDOZ PRIVATE LIMITED — $72.0M. 3. TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED — $62.5M. 88 buyers total.

What pharmaceutical products does India export most to Italy?

1. Valsartan ($103.0M, 21.8%); 2. Serum ($84.5M, 17.9%); 3. Insulin ($78.0M, 16.5%); 4. Prednisolone ($57.5M, 12.2%); 5. Methylprednisolone ($49.0M, 10.4%)

Why does Italy import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $471.9M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Italy?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Italy pharmaceutical trade?

$275.9K per consignment across 1,710 shipments.

How many Indian pharmaceutical companies export to Italy?

133 Indian companies. Largest: PFIZER SERVICE COMPANY BV with $79.5M.

How can I find verified Indian pharmaceutical suppliers for Italy?

TransData Nexus covers 133 active exporters with shipment history and trade values at transdatanexus.com.

Italy to India Pharmaceutical Import (2026) — $471.9M, 133 Foreign Suppliers | TransData Nexus

Q: Who are the top Indian pharmaceutical exporters to Italy?

1. PFIZER SERVICE COMPANY BV — $79.5M. 2. Takeda Pharmaceuticals International AG — $71.0M. 3. NOVARTIS PHARMA AG — $67.5M. Total: 133 suppliers.

Italy to India Pharmaceutical Import (2026) — $471.9M, 133 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Italy to India

#	Formulation	Value	Share
1	Valsartan	$103.0M	21.8%
2	Serum	$84.5M	17.9%
3	Insulin	$78.0M	16.5%
4	Prednisolone	$57.5M	12.2%
5	Methylprednisolone	$49.0M	10.4%
6	Vaccine	$20.8M	4.4%
7	Teicoplanin	$20.0M	4.2%
8	Canagliflozin	$18.0M	3.8%
9	Sodium	$10.1M	2.1%
10	Cefuroxime	$9.6M	2.0%
11	Sunitinib	$5.0M	1.1%
12	Darunavir	$3.1M	0.7%
13	Mycophenolate	$2.7M	0.6%
14	Budesonide	$2.5M	0.5%
15	Protein	$1.8M	0.4%

India imports 20+ pharmaceutical formulations from Italy with a combined trade value of $471.9M. Key products include Valsartan ($103.0M), Serum ($84.5M), Insulin ($78.0M), Prednisolone ($57.5M), Methylprednisolone ($49.0M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1,710 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Italy to India Trade Routes

1Valsartan$103.0M

2Serum$84.5M

3Insulin$78.0M

4Prednisolone$57.5M

5Methylprednisolone$49.0M

6Vaccine

Top Italy Suppliers to India

1Pfizer Service Company Bv

$79.5M

2Takeda Pharmaceuticals International Ag

$71.0M

3Novartis Pharma Ag

$67.5M

4Eli Lilly Export S.a.

$57.5M

5Glaxosmithkline Export Limited

$19.2M

Trade Statistics

Total Value$471.9M

Shipments1,710

Indian Exporters133

Italy Buyers88

Avg Shipment$276K

Products101

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M France

Last updated: March 28, 2026

India–Italy Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between Italy and India has experienced significant growth over the past decade. In 2022, the total import value stood at $471.9 million USD, with 1,710 shipments from 133 Italian suppliers to 88 Indian buyers. This reflects a robust and expanding trade relationship, underscoring Italy's increasing role in supplying pharmaceutical products to the Indian market.

Key milestones in this evolution include the establishment of streamlined regulatory processes and enhanced logistical frameworks. The introduction of the CDSCO's SUGAM portal in 2016 facilitated more efficient registration and approval procedures for foreign pharmaceutical companies, including those from Italy. This digitalization has significantly reduced processing times and improved transparency in the import process.

2Italy's Role in India's Pharma Imports

Italy has become a significant contributor to India's pharmaceutical imports, with a total import value of $471.9 million USD over the past five years. The top 10 imported products from Italy include valsartan ($103.0 million, 21.8%), serum ($84.5 million, 17.9%), insulin ($78.0 million, 16.5%), and prednisolone ($57.5 million, 12.2%). These products highlight Italy's strength in supplying essential medications, particularly in the cardiovascular and endocrine therapeutic areas.

Italian pharmaceutical companies such as Pfizer Service Company BV, Takeda Pharmaceuticals International AG, and Novartis Pharma AG have been instrumental in this trade, supplying a diverse range of products to meet India's growing healthcare needs. Their consistent presence underscores the trust and demand for Italian pharmaceutical products in the Indian market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Italy identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 1,710 verified shipments from 133 Indian exporters to 88 Italy buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

133 Exporters

88 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Italy to India Pharmaceutical Import

Top Pharmaceutical Formulations — Italy to India

Top Pharmaceutical Products — Italy to India Trade Routes

Top Italy Suppliers to India

Trade Statistics

Other Import Origins

India–Italy Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2Italy's Role in India's Pharma Imports

Top Indian Buyers from Italy

Product Routes

Full Dataset Access

3Recent Developments

Italy Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to Italy

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and Italy

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control

Supply Chain & Logistics — India to Italy Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Indian Customs & Cold Chain

Market Opportunity Assessment — Italy for Indian Pharma

1India's Import Dependency

2Italy Companies in India

FAQ — India to Italy Pharmaceutical Trade